Evaluation location: New York, United States
Screening of hemp germplasm from 2022 USDA-ARS PGRU phenotyping trial in Research North 010. Trial included 100 accessions, three replications, approximately 10 plants per plot. Evaluation occurred on the individual plant level. Data is presented as means across all individuals.